OptimizeRx Corporation

NASDAQ

Market Cap.

183.27M

Avg. Volume

528.16K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about OptimizeRx Corporation

OptimizeRx Corporation News

OptimizeRx Corporation Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareMedical - Healthcare Information Services
optimizerx.com

About OptimizeRx Corporation

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.

OptimizeRx Corporation Earnings & Revenue

OptimizeRx Corporation Financials

Table Compare

Compare OPRX metrics with:

   

Earnings & Growth

OPRX

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

OPRX

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

OPRX

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

OPRX

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

OptimizeRx Corporation Income

OptimizeRx Corporation Balance Sheet

OptimizeRx Corporation Cash Flow

OptimizeRx Corporation Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Sell
Return on EquityStrong Sell
Return on AssetsStrong Sell
Debt/Equity RatioSell
Price/Earnings RatioStrong Sell
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

OptimizeRx Corporation Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Historical Market Cap

Shares Outstanding

OptimizeRx Corporation Executives

NameRole
Mr. Edward Stelmakh C.M.A., M.B.A.Chief Financial Officer & Chief Operating Officer
Mr. Stephen L. SilvestroPresident & Chief Executive Officer
Ms. Marion K Odence-FordChief Legal Officer & Chief Human Resources Officer
Ms. Maira AlejandraMedia Relations Manager
Ms. Theresa GrecoChief Commercial Officer
NameRoleGenderDate of BirthPay
Mr. Edward Stelmakh C.M.A., M.B.A.Chief Financial Officer & Chief Operating OfficerMale1966578.48K
Mr. Stephen L. SilvestroPresident & Chief Executive OfficerMale1978544.96K
Ms. Marion K Odence-FordChief Legal Officer & Chief Human Resources OfficerFemale1965428.12K
Ms. Maira AlejandraMedia Relations ManagerFemale

--

Ms. Theresa GrecoChief Commercial OfficerFemale1973

--

OptimizeRx Corporation Insider Trades

Date14 Mar
NameLang James Paul
RoleDirector
TransactionAcquired
TypeP-Purchase
Shares321408
Date1 Mar
NameSilvestro Stephen L
RoleChief Commercial Officer
TransactionAcquired
TypeM-Exempt
Shares1928
Date1 Mar
NameSilvestro Stephen L
RoleChief Commercial Officer
TransactionDisposed
TypeF-InKind
Shares572
Date1 Mar
NameSilvestro Stephen L
RoleChief Commercial Officer
TransactionDisposed
TypeM-Exempt
Shares1928
Date1 Mar
NameOdence-Ford Marion
RoleChief Legal Officer & CHRO
TransactionAcquired
TypeM-Exempt
Shares771
DateNameRoleTransactionTypeShares
14 MarLang James PaulDirectorAcquiredP-Purchase321408
1 MarSilvestro Stephen LChief Commercial OfficerAcquiredM-Exempt1928
1 MarSilvestro Stephen LChief Commercial OfficerDisposedF-InKind572
1 MarSilvestro Stephen LChief Commercial OfficerDisposedM-Exempt1928
1 MarOdence-Ford MarionChief Legal Officer & CHROAcquiredM-Exempt771

Discover More

Streamlined Academy

OptimizeRx Corporation

NASDAQ

Market Cap.

183.27M

Avg. Volume

528.16K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

OptimizeRx Corporation News

OptimizeRx Corporation Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

OptimizeRx Corporation Earnings & Revenue

OptimizeRx Corporation Income

OptimizeRx Corporation Balance Sheet

OptimizeRx Corporation Cash Flow

OptimizeRx Corporation Financials Over Time

OptimizeRx Corporation Executives

NameRole
Mr. Edward Stelmakh C.M.A., M.B.A.Chief Financial Officer & Chief Operating Officer
Mr. Stephen L. SilvestroPresident & Chief Executive Officer
Ms. Marion K Odence-FordChief Legal Officer & Chief Human Resources Officer
Ms. Maira AlejandraMedia Relations Manager
Ms. Theresa GrecoChief Commercial Officer
NameRoleGenderDate of BirthPay
Mr. Edward Stelmakh C.M.A., M.B.A.Chief Financial Officer & Chief Operating OfficerMale1966578.48K
Mr. Stephen L. SilvestroPresident & Chief Executive OfficerMale1978544.96K
Ms. Marion K Odence-FordChief Legal Officer & Chief Human Resources OfficerFemale1965428.12K
Ms. Maira AlejandraMedia Relations ManagerFemale

--

Ms. Theresa GrecoChief Commercial OfficerFemale1973

--

OptimizeRx Corporation Insider Trades

Date14 Mar
NameLang James Paul
RoleDirector
TransactionAcquired
TypeP-Purchase
Shares321408
Date1 Mar
NameSilvestro Stephen L
RoleChief Commercial Officer
TransactionAcquired
TypeM-Exempt
Shares1928
Date1 Mar
NameSilvestro Stephen L
RoleChief Commercial Officer
TransactionDisposed
TypeF-InKind
Shares572
Date1 Mar
NameSilvestro Stephen L
RoleChief Commercial Officer
TransactionDisposed
TypeM-Exempt
Shares1928
Date1 Mar
NameOdence-Ford Marion
RoleChief Legal Officer & CHRO
TransactionAcquired
TypeM-Exempt
Shares771
DateNameRoleTransactionTypeShares
14 MarLang James PaulDirectorAcquiredP-Purchase321408
1 MarSilvestro Stephen LChief Commercial OfficerAcquiredM-Exempt1928
1 MarSilvestro Stephen LChief Commercial OfficerDisposedF-InKind572
1 MarSilvestro Stephen LChief Commercial OfficerDisposedM-Exempt1928
1 MarOdence-Ford MarionChief Legal Officer & CHROAcquiredM-Exempt771

Streamlined Academy

Website screenshot
HealthcareMedical - Healthcare Information Services
optimizerx.com

About OptimizeRx Corporation

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about OptimizeRx Corporation

OptimizeRx Corporation Financials

Table Compare

Compare OPRX metrics with:

   

Earnings & Growth

OPRX

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

OPRX

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

OPRX

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

OPRX

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

OptimizeRx Corporation Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Sell
Return on EquityStrong Sell
Return on AssetsStrong Sell
Debt/Equity RatioSell
Price/Earnings RatioStrong Sell
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

A Practical Guide: How To Analyze Any Stock (With Examples)